Role of vascular endothelial growth factor-A in development of abdominal aortic aneurysm

Cardiovascular Research

Volumn 91, Issue 2, 2011, Pages 358-367

  Kaneko, Hidehiro ^a   Anzai, Toshihisa ^a,d   Takahashi, Toshiyuki ^a   Kohno, Takashi ^a   Shimoda, Masayuki ^a   Sasaki, Aya ^a   Shimizu, Hideyuki ^a   Nagai, Toshiyuki ^a   Maekawa, Yuichiro ^a   Yoshimura, Koichi ^b   Aoki, Hiroki ^c   Yoshikawa, Tsutomu ^a   Okada, Yasunori ^a   Yozu, Ryohei ^a   Ogawa, Satoshi ^d   Fukuda, Keiichi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d International University of Health and Welfare Mita Hospital   (Japan)

Author keywords

Angio arteriogenesis; Atherosclerosis; Growth factors; Inflammation; Macrophages

Indexed keywords

CALCIUM CHLORIDE; CD31 ANTIGEN; GELATINASE A; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ARTICLE; CD3+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MACROPHAGE MIGRATION; MALE; NEOVASCULARIZATION (PATHOLOGY); PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGED; ANALYSIS OF VARIANCE; ANIMALS; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; AORTOGRAPHY; CALCIUM CHLORIDE; CHI-SQUARE DISTRIBUTION; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HEMODYNAMICS; HUMANS; INFLAMMATION MEDIATORS; INJECTIONS, INTRAPERITONEAL; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RECOMBINANT PROTEINS; RNA, MESSENGER; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 79960005595     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr080     Document Type: Article

References (35)

1. Weintraub NL. Understanding abdominal aortic aneurysm. N Engl J Med 2009;361: 1114-1116.
2. Kadoglou NP, Liapis CD. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms. Curr Med Res Opin 2004;20:419-432. (Pubitemid 38525149)
3. Choke E, Cockerill G, Wilson WR, Sayed S, Dawson J, Loftus I et al. A review of biological factors implicated in abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg 2005;30:227-244. (Pubitemid 41086292)
4. Thompson MM, Jones L, Nasim A, Sayers RD, Bell PR. Angiogenesis in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 1996;11:464-469. (Pubitemid 26192856)
5. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marme D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 1996;87:3336-3343. (Pubitemid 26115364)
6. Clauss M, Weich H, Breier G, Knies U, Rockl W, Waltenberger J et al. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 1996;271:17629-17634. (Pubitemid 26250731)
7. Jin X, Ge X, Zhu DL, Yan C, Chu YF, Chen WD et al. Expression and function of vascular endothelial growth factor receptors (Flt-1 and Flk-1) in vascular adventitial fibroblasts. J Mol Cell Cardiol 2007;43:292-300. (Pubitemid 47304445)
8. Sawano A, Iwai S, Sakurai Y, Ito M, Shitara K, Nakahata T et al. Flt-1, vascular endo-thelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood 2001;97:785-791. (Pubitemid 32113414)
9. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003;9:669-676. (Pubitemid 36749215)
10. Hamada N, Kuwano K, Yamada M, Hagimoto N, Hiasa K, Egashira K et al. Anti-vascular endothelial growth factor gene therapy attenuates lung injury and fibrosis in mice. J Immunol 2005;175:1224-1231. (Pubitemid 41095011)
11. Zhao Q, Egashira K, Inoue S, Usui M, Kitamoto S, Ni W et al. Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis. Circulation 2002;105:1110-1115. (Pubitemid 34212623)
12. Miotla J, Maciewicz R, Kendrew J, Feldmann M, Paleolog E. Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis. Lab Invest 2000;80:1195-1205. (Pubitemid 30637059)
13. Tsao PN, Chan FT, Wei SC, Hsieh WS, Chou HC, Su YN et al. Soluble vascular endothelial growth factor receptor-1 protects mice in sepsis. Crit Care Med 2007; 35:1955-1960.
14. Naito K, Anzai T, Sugano Y, Maekawa Y, Kohno T, Yoshikawa T et al. Differential effects of GM-CSF and G-CSF on infiltration of dendritic cells during early left ventricular remodeling after myocardial infarction. J Immunol 2008;181: 5691-5701.
15. Takahashi T, Anzai T, Yoshikawa T, Maekawa Y, Mahara K, Iwata M et al. Angiotensin receptor blockade improves myocardial beta-adrenergic receptor signaling in postinfarction left ventricular remodeling: a possible link between beta-adrenergic receptor kinase-1 and protein kinase C epsilon isoform. J Am Coll Cardiol 2004;43: 125-132. (Pubitemid 38045926)
16. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT. Matrix metallopro-teinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 2002; 110:625-632. (Pubitemid 34988786)
17. Fukamizu A, Sugimura K, Takimoto E, Sugiyama F, Seo MS, Takahashi S et al. Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of trans-genic mice carrying both human renin and human angiotensinogen genes. J Biol Chem 1993;268:11617-11621. (Pubitemid 23168109)
18. Sugano Y, Anzai T, Yoshikawa T, Maekawa Y, Kohno T, Mahara K et al. Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction. Cardiovasc Res 2005;65:446-456. (Pubitemid 40082487)
19. Barger AC, Beeuwkes R 3rd, Lainey LL, Silverman KJ. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med 1984;310:175-177. (Pubitemid 14224112)
20. Moreno PR, Purushothaman KR, Sirol M, Levy AP, Fuster V. Neovascularization in human atherosclerosis. Circulation 2006;113:2245-2252.
21. Maiellaro K, Taylor WR. The role of the adventitia in vascular inflammation. Cardiovasc Res 2007;75:640-648. (Pubitemid 47238746)
22. Moulton KS, Heller E, Konerding MA, Flynn E, Palinski W, Folkman J. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 1999;99: 1726-1732. (Pubitemid 29162486)
23. Paik DC, Fu C, Bhattacharya J, Tilson MD. Ongoing angiogenesis in blood vessels of the abdominal aortic aneurysm. Exp Mol Med 2004;36:524-533. (Pubitemid 40129174)
24. Choke E, Thompson MM, Dawson J, Wilson WR, Sayed S, Loftus IM et al. Abdominal aortic aneurysm rupture is associated with increased medial neovascularization and overexpression of proangiogenic cytokines. Arterioscler Thromb Vasc Biol 2006;26: 2077-2082. (Pubitemid 44253791)
25. Tedesco MM, Terashima M, Blankenberg FG, Levashova Z, Spin JM, Backer MV et al. Analysis of in situ and ex vivo vascular endothelial growth factor receptor expression during experimental aortic aneurysm progression. Arterioscler Thromb Vasc Biol 2009; 29:1452-1457.
26. Miyake T, Aoki M, Masaki H, Kawasaki T, Oishi M, Kataoka K et al. Regression of abdominal aortic aneurysms by simultaneous inhibition of nuclear factor kappaB and ets in a rabbit model. Circ Res 2007;101:1175-1184. (Pubitemid 350146444)
27. Stannard AK, Khurana R, Evans IM, Sofra V, Holmes DI, Zachary I. Vascular endo-thelial growth factor synergistically enhances induction of E-selectin by tumor necrosis factor-alpha. Arterioscler Thromb Vasc Biol 2007;27:494-502.
28. Casella I, Feccia T, Chelucci C, Samoggia P, Castelli G, Guerriero R et al. Autocrine-paracrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptor. Blood 2003;101:1316-1323. (Pubitemid 36182501)
29. Kim YS, Hong SW, Choi JP, Shin TS, Moon HG, Choi EJ et al. Vascular endothelial growth factor is a key mediator in the development of T cell priming and its polarization to type 1 and type 17 T helper cells in the airways. J Immunol 2009;183: 5113-5120.
30. Hiratsuka S, Nakamura K, Iwai S, Murakami M, Itoh T, Kijima H et al. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2002;2:289-300. (Pubitemid 41043963)
31. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2:161-174. (Pubitemid 37328786)
32. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25. (Pubitemid 27076453)
33. Yoshimura K, Aoki H, Ikeda Y, Fujii K, Akiyama N, Furutani A et al. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat Med 2005; 11:1330-1338. (Pubitemid 41752914)
34. Choke E, Cockerill GW, Dawson J, Howe F, Wilson WR, Loftus IM et al. Vascular endothelial growth factor enhances angiotensin II-induced aneurysm formation in apolipoprotein E-deficient mice. J Vasc Surg 2010;52:159-166.
35. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-2342. (Pubitemid 38702844)